Linked Life Data

2655043

Source:http://linkedlifedata.com/resource/pubmed/id/2655043

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1989-6-19
pubmed:abstractText
The therapeutic results obtained in 27 patients with severe aplastic anemia (SAA) have been studied retrospectively. Ten patients underwent allogenic bone marrow transplantation (BMT) and 17 received antithymocyte globulin (ATG). Five of the ten patients transplanted (50%) are living and show normal hemopoiesis. Although prophylaxis was used, the incidence of host-versus-graft disease (grade II-IV) was 40% and concomitant pneumonitis was the main cause of death. Twenty courses of ATG were given to the 17 patients. 12 responses were achieved (60%), of which two were complete and the remaining were partial. Two patients who did not respond initially and one who recurred responded to a second course. Eleven patients survived (64.7%) of which 10 were disease-free (58.8%). One of them had remission controlled with cyclosporine. The probability of long-term survival is 48% in the group transplanted and 61.6% in the group treated with ATG, showing no statistical differences.
pubmed:language
spa
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0014-2565
pubmed:author
pubmed:issnType
Print
pubmed:volume
184
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
121-4
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1989
pubmed:articleTitle
[Treatment of severe aplastic anemia with bone marrow transplants or with antithymocyte globulin. Evaluation of 27 patients].
pubmed:publicationType
Journal Article, Comparative Study, English Abstract